Triple
T7933375
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Verily |
E184233
|
entity |
| Predicate | formerName |
P65
|
FINISHED |
| Object | Google Life Sciences |
E35319
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Google Life Sciences | Statement: [Verily, formerName, Google Life Sciences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Google Life Sciences Context triple: [Verily, formerName, Google Life Sciences]
-
A.
Verily Life Sciences LLC
chosen
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
-
B.
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
C.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
D.
Array BioPharma
Array BioPharma is a biopharmaceutical company known for developing targeted small-molecule cancer therapies, particularly in oncology and rare diseases.
-
E.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca8290c21c8190906a5ca6fe2b03c4 |
completed | March 30, 2026, 2:02 p.m. |
| NER | Named-entity recognition | batch_69cb3acfd2a88190b1a13cd6fdedc272 |
completed | March 31, 2026, 3:09 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69cb5c041e588190bfbf251ed88d5bcd |
completed | March 31, 2026, 5:30 a.m. |
Created at: March 30, 2026, 5:08 p.m.